The latest biotech news

News and Trends 6 Feb 2020

Lunaphore Raises €21.5M to Develop Automated Cancer Research Tools

Swiss company Lunaphore Technologies has raised €21.5M (CHF 23M) in Series C funding to expand the automation of cancer research and tissue diagnostics in Europe and the US. The oversubscribed funding round was completed in mid-January and was led by Japan-based PHC Holdings Corporation, with further contributions from existing investors including Redalpine Venture Partners, OCCIDENT […]

February 6, 2020 - 2 minutesmins - By External Contributor

dna synthesis synthetic biology cambridge

News and Trends 6 Feb 2020

Camena Bioscience Hits DNA Synthesis Milestone

Camena Bioscience has achieved a significant DNA synthesis milestone by reproducing the DNA sequence of a whole plasmid, which could be used in synthetic biology applications such as protein production and bacterial engineering. DNA synthesis is a field that, until recently, had not been a focus for companies developing innovative technologies, with greater importance being […]

February 6, 2020 - 3 minutesmins - By External Contributor

News and Trends 6 Feb 2020

Valbiotis Teams up with Nestlé to Reduce Type 2 Diabetes Risk

In a deal worth up to €67M, industry giant Nestlé Health Science will have the global rights to commercialize Valbiotis’ food supplement for lowering the rate of type 2 diabetes in people at high risk of developing the condition. Under the terms of the deal, the French biotech will receive an upfront payment of €4.7M […]

February 6, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 5 Feb 2020

MaaT Pharma’s Microbiome Cancer Treatment Given €18M Boost

French company MaaT Pharma has raised €18M in Series B financing that will support phase Ib and II trials of its biotherapeutic drug, which aims to restore the microbiome and improve outcomes in patients with various types of blood cancer and solid tumors. The financing round included French microbiome-focused investor Symbiosis, as well as support […]

February 5, 2020 - 3 minutesmins - By External Contributor

News and Trends 4 Feb 2020

Swiss Biotech Raises €16M to Treat Autism Spectrum Disorder

Stalicla has bagged €16.3M in a Series A round to test drugs repurposed using AI for the treatment of autism spectrum disorder in phase I. The round consists of a recent €7M (CHF 7.7M) closing and an initial first tranche of €9.3M (CHF 10M) raised last year. The investors in the latest closing were not […]

February 4, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 3 Feb 2020

CureVac Bids to Develop First mRNA Coronavirus Vaccine

RNA vaccine developer CureVac will receive a grant of up to €8.3M from a global partnership to develop an mRNA vaccine against the new coronavirus strain from China. The agreement follows on from an existing collaboration launched in 2019, when the Coalition for Epidemic Preparedness Innovations, or CEPI, granted CureVac €30M to develop facilities that […]

February 3, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 1 Feb 2020

Cardior Pharmaceuticals’ Heart Failure Drug Shows Curative Potential

German biotech company Cardior Pharmaceuticals’ candidate heart failure drug has the potential to stop the condition in its tracks, according to early studies in animal models. At present, treatments for heart failure, including ACE inhibitors, beta blockers, and diuretics, target the symptoms of the disease, such as high blood pressure, rather than the actual cause. […]

February 1, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 31 Jan 2020

AI-Designed Drug Enters Phase I to Treat OCD

A drug designed by the UK firm Exscientia using AI-powered software has entered into a phase I clinical trial for the treatment of obsessive-compulsive disorder, commonly known as OCD. The clinical development of the drug will be carried out by Sumitomo Dainippon Pharma, Exscientia’s Japanese collaborator. The drug took just 12 months to get to […]

January 31, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 30 Jan 2020

Austrian Genomics Company Joins Fight Against Coronavirus

Ares Genetics will use next-generation sequencing technology from the Chinese genomics company BGI Group to track and control the spread of a new coronavirus originating in China. A new strain of coronavirus, dubbed 2019-nCoV and originating in the Chinese city of Wuhan, has caused widespread concern in recent weeks. While only 20% of people with […]

January 30, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 29 Jan 2020

Oxitec Unveils First Field Trial Results for Crop-Protecting GM Moths

A study led by Oxitec has shown for the first time that diamondback moths genetically engineered to produce only male offspring can survive in the wild, a solution that shows promise for cutting populations of the crop pest. Caterpillars of the diamondback moth Plutella xylostella are one of the most destructive pests for growers of […]

January 29, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 28 Jan 2020

A Future Gene Therapy Could Be Delivered in Tiny ‘Nanocontainers’

A Swiss research group has developed tiny plastic particles that could carry gene therapies to the center of the cell with less risk of getting attacked by the immune system than conventional gene therapies. The majority of gene therapies in use today are delivered to the DNA of target cells using viral vectors. While efficient […]

January 28, 2020 - 3 minutesmins - By Jonathan Smith

cancer vaccine cancer immunotherapy ervaxx

News and Trends 27 Jan 2020

UK Startup Snaps up Potential Universal Cancer Immunotherapy

The cancer vaccine developer Ervaxx has licensed a preclinical-stage ‘universal’ cancer immunotherapy based on the recent discovery of a new strain of immune T-cells at Cardiff University, UK. Last week, a team led by researchers at Cardiff University published research about T-cells capable of hunting a wide range of cancers including leukemia and melanoma. Experiments […]

January 27, 2020 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Lunaphore Raises €21.5M to Develop Automated Cancer Research Tools

Camena Bioscience Hits DNA Synthesis Milestone

Valbiotis Teams up with Nestlé to Reduce Type 2 Diabetes Risk

MaaT Pharma’s Microbiome Cancer Treatment Given €18M Boost

Swiss Biotech Raises €16M to Treat Autism Spectrum Disorder

CureVac Bids to Develop First mRNA Coronavirus Vaccine

Cardior Pharmaceuticals’ Heart Failure Drug Shows Curative Potential

AI-Designed Drug Enters Phase I to Treat OCD

Austrian Genomics Company Joins Fight Against Coronavirus

Oxitec Unveils First Field Trial Results for Crop-Protecting GM Moths

A Future Gene Therapy Could Be Delivered in Tiny ‘Nanocontainers’

UK Startup Snaps up Potential Universal Cancer Immunotherapy

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!